Iovance Biotherapeutics (IOVA) EBT Margin (2019 - 2026)
Iovance Biotherapeutics (IOVA) recorded EBT Margin of -49.02% in Q2 2026, up 133.90 percentage points from -182.93% a year earlier and up 62.57 percentage points from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) EBT Margin (2019 - 2026) Analysis & Trends
On a TTM basis, Iovance Biotherapeutics' EBT Margin came in at -90.40% as of Jun 30, 2026, up 70.96 percentage points year-over-year; for FY2025, it was -149.16%, up 79.40 percentage points from FY2024.
- Across earlier years, EBT Margin came in at -228.56% in FY2024 (+37409.45 pp) and -37638.02% in FY2023.
- The Q2 2026 figure is the highest quarterly EBT Margin in data going back to Q2 2023.
- On a year-over-year basis, EBT Margin has increased for nine consecutive quarters, with an average year-over-year change of +8120.42 percentage points over the last eight quarters.
- Over the past five years, the year-over-year gain in EBT Margin ranged from 6.42 percentage points (Q3 2025) to 44643.24 percentage points (Q2 2024).
- Per Business Quant, the preceding three quarters came in at -111.59% (Q1 2026), -82.65% (Q4 2025) and -138.85% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn | -17.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -17.83% |
| Jun 30, 2026 | -49.02% |
| Mar 31, 2026 | -111.59% |
| Dec 31, 2025 | -82.65% |
| Sep 30, 2025 | -138.85% |
| Jun 30, 2025 | -182.93% |
| Mar 31, 2025 | -239.24% |
| Dec 31, 2024 | -104.49% |
| Sep 30, 2024 | -145.27% |
| Jun 30, 2024 | -316.85% |
| Mar 31, 2024 | -15,997.76% |
| Dec 31, 2023 | -24,509.96% |
| Sep 30, 2023 | -24,520.90% |
| Jun 30, 2023 | -44,960.08% |
| Mar 31, 2023 | -3,080.03% |
| Dec 31, 2022 | -6,133.90% |
| Sep 30, 2022 | -12,820.85% |
| Jun 30, 2022 | -25,804.94% |
| Mar 31, 2022 | -86,421.70% |
| Dec 31, 2021 | -73,577.78% |
API Access
Iovance Biotherapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();